about
Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5Oligonucleotide-based knockdown technologies: antisense versus RNA interference.Antisense oligonucleotides as therapeutic agents.Antisense DNAs as multisite genomic modulators identified by DNA microarrayHER2/neu antisense targeting of human breast carcinoma.RNA therapeutics: beyond RNA interference and antisense oligonucleotides.Specificity of short interfering RNA determined through gene expression signatures.Dicer-substrate siRNA inhibits tumor necrosis factor alpha secretion in Kupffer cells in vitro: in vivo targeting of Kupffer cells by siRNA-liposomes.Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a targetAntileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo.Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistanceInhibition of tumor necrosis factor alpha secretion in rat Kupffer cells by siRNA: in vivo efficacy of siRNA-liposomes.Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells.Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotidesSequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivoPhosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity.Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth.Synthetic antisense oligodeoxynucleotides to transiently suppress different nucleus- and chloroplast-encoded proteins of higher plant chloroplasts.CO2 response for expression of ribulose-1,5-bisphosphate carboxylase/oxygenase genes is inhibited by AT-rich decoy in the cyanobacterium.Smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase A2beta.Knockdown of RARB2 identifies a dual role in cancer.Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency.Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules.Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages.Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression.c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter.Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent.Local delivery of c-myc neutrally charged antisense oligonucleotides with transport catheter inhibits myointimal hyperplasia and positively affects vascular remodeling in the rabbit balloon injury model.Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells.Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide.Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A.Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.
P2860
Q28573534-B1F0D2D8-3C6D-4CC7-B6F6-E11E195419EEQ33193599-AA18BF0C-E7A0-4D0E-8714-0BFB9327E91EQ33738466-787E10E9-70F1-4205-8869-B52903AB4AF0Q33933892-4467EE76-466D-4DEC-8C07-9CA1FEB6910EQ34130563-A16F024C-709E-4912-A4C1-5FBDEFA3846EQ34248493-DCF311EB-3DC3-44AC-9E60-8CEA3124EDBCQ35142877-827177DF-F1CD-4B99-82EB-878CD5B2E397Q35690977-16B000F6-F1B5-46A6-9CAD-20839CD0F175Q35899878-C410E3CF-0A4A-406E-A566-EAF2B6CA9251Q36108131-32863AB3-4897-41E5-AFCD-4E5DF5DE255DQ36254793-7865DFC1-8D8B-4C10-A778-3DD4824D1DC1Q36334316-C4CA00E9-A63E-4F5B-B72E-9D3A8705C404Q36437931-D1B25877-1C4A-40CA-B943-320C8F85353EQ36671167-790CFD4D-484D-49EA-98CD-185548DF4D05Q36673652-C0BB7369-27C6-4659-9385-3E556123F650Q36684554-9C378FD3-A0A1-45BF-A6F1-5CC092D33640Q37097859-34B9A415-3015-4974-BA60-3B1F46B11768Q38290188-346827F6-A51F-48EF-9FEE-B11E3298D117Q38329699-E544455B-2626-44E7-9726-8B47AC5E7BEEQ38331315-05629D96-B9C7-4640-824B-97A39FEEAE05Q38354991-4D6DFFC8-62A5-4CF5-AC38-A225D430A3B8Q38498393-2B5F2386-74FD-4FD3-ABBB-D83CB5E53271Q39531093-3084FCF6-369F-4244-9E15-3102EEBE8125Q39716115-FCAFCA0A-8042-420D-94AD-83627F8D6812Q39717027-244A95F5-B1FC-49F9-BA33-E7CFA223A610Q40404687-17327C36-BF74-494C-84C9-07060FE22991Q40448608-2B30C6F2-64C0-4DB7-ACB9-4383CB14D7F8Q40456753-084109CE-DE59-458B-9F90-4FBF9F27809EQ41141202-473D3ADF-5EDE-4096-8427-D048C802E22BQ42002200-9DCF35A0-2930-4EA3-87F3-2CA5ABC79D11Q42435037-46E6327B-4F1B-4005-B642-6ADBFAB4FDFDQ42477692-9787018D-776C-4C63-A02E-901BED64A2DFQ42478691-59A8C233-382B-4325-A875-506B4F5F3C57Q43759394-1A46762E-F322-4521-B79A-6B77AFD83322Q44279405-730FE13A-B5D1-4A60-808E-EBA60B071800Q44283775-E7B6E537-65B5-4F4B-9502-34FD2C494D64Q48379910-06496C13-61E8-4BEA-8B22-47525286BD00Q50587585-B8B184B5-AF04-45C6-9BA0-D418E41EC741Q54123869-66F31DEA-3B0E-4C6D-B159-6E0B7BA04DB6
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Does antisense exist?
@en
type
label
Does antisense exist?
@en
prefLabel
Does antisense exist?
@en
P2860
P356
P1433
P1476
Does antisense exist?
@en
P2093
P2860
P2888
P304
P356
10.1038/NM1195-1119
P407
P577
1995-11-01T00:00:00Z
P6179
1052115793